The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Leslie, Kimberly K., Thiel, Kristina W., Reyes, Henry D., Yang, Shujie, Zhang, Yuping, Carlson, Matthew J., Kumar, Nirmala S., Dai, Donghai D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816067/
https://www.ncbi.nlm.nih.gov/pubmed/24223042
http://dx.doi.org/10.1155/2013/479541
_version_ 1782289489837686784
author Leslie, Kimberly K.
Thiel, Kristina W.
Reyes, Henry D.
Yang, Shujie
Zhang, Yuping
Carlson, Matthew J.
Kumar, Nirmala S.
Dai, Donghai D.
author_facet Leslie, Kimberly K.
Thiel, Kristina W.
Reyes, Henry D.
Yang, Shujie
Zhang, Yuping
Carlson, Matthew J.
Kumar, Nirmala S.
Dai, Donghai D.
author_sort Leslie, Kimberly K.
collection PubMed
description Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor as the most studied biomarker and the best predictor for response for endometrial cancer reported to date.
format Online
Article
Text
id pubmed-3816067
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38160672013-11-12 The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome Leslie, Kimberly K. Thiel, Kristina W. Reyes, Henry D. Yang, Shujie Zhang, Yuping Carlson, Matthew J. Kumar, Nirmala S. Dai, Donghai D. Obstet Gynecol Int Review Article Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor as the most studied biomarker and the best predictor for response for endometrial cancer reported to date. Hindawi Publishing Corporation 2013 2013-10-07 /pmc/articles/PMC3816067/ /pubmed/24223042 http://dx.doi.org/10.1155/2013/479541 Text en Copyright © 2013 Kimberly K. Leslie et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Leslie, Kimberly K.
Thiel, Kristina W.
Reyes, Henry D.
Yang, Shujie
Zhang, Yuping
Carlson, Matthew J.
Kumar, Nirmala S.
Dai, Donghai D.
The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title_full The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title_fullStr The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title_full_unstemmed The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title_short The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
title_sort estrogen receptor joins other cancer biomarkers as a predictor of outcome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816067/
https://www.ncbi.nlm.nih.gov/pubmed/24223042
http://dx.doi.org/10.1155/2013/479541
work_keys_str_mv AT lesliekimberlyk theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT thielkristinaw theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT reyeshenryd theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT yangshujie theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT zhangyuping theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT carlsonmatthewj theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT kumarnirmalas theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT daidonghaid theestrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT lesliekimberlyk estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT thielkristinaw estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT reyeshenryd estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT yangshujie estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT zhangyuping estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT carlsonmatthewj estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT kumarnirmalas estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome
AT daidonghaid estrogenreceptorjoinsothercancerbiomarkersasapredictorofoutcome

Ejemplares similares